Cyber Attacks on NHS Put Over 50 Patients at Risk, Spark Urgent Calls for Stronger Cyber Resilience

Two major cyber incidents targeting the UK’s NHS in 2023 resulted in potential clinical harm to dozens of patients, underscoring the growing threat of ransomware to public health.

Yu Chi Huang
By
Yu Chi Huang
Yu Chi is a senior regulatory affairs specialist and medical researcher focusing on medical devices.
2 Min Read

As first reported by The Record by Recorded Future News, newly obtained government data reveals that two cyber attacks targeting the NHS in 2023 posed risks of clinical harm to over 50 patients. While no deaths were recorded, the incidents highlight the increasing danger posed by financially motivated cybercriminals to healthcare operations and patient outcomes. One of the likely incidents was the ransomware attack on Synnovis, which severely disrupted pathology services across several London hospitals, delaying surgeries and essential care.

Source: synnovis.co.uk.

Another reported case involved Wirral University Teaching Hospital NHS Foundation Trust, where cancer treatments were delayed due to system outages. These disruptions, categorized under the third-highest severity level of the UK’s Network and Information Systems (NIS) Regulations, show that critical service interruptions can have a direct impact on patient safety—even if they fall short of resulting in fatalities.

- Advertisement -

Systemic Risks and Calls for Reform

The Health Services Safety Investigations Body (HSSIB) has warned that cyberattacks disrupting Electronic Patient Records (EPRs) and diagnostics pose serious risks to patient safety and add strain to overstretched healthcare staff. In response, the UK government plans to introduce the Cyber Security and Resilience Bill to expand regulations to critical suppliers like software vendors. NHS leaders are also pushing for stronger defenses against ransomware, with officials stressing that cybersecurity is now essential to protecting both healthcare systems and patient lives.

Share This Article
Yu Chi is a senior regulatory affairs specialist and medical researcher focusing on medical devices.
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *